AI-Enhanced Minimally Invasive Devices Market Size is valued at US$ 5.7 Bn in 2024 and is predicted to reach US$ 27.8 Bn by the year 2034 at an 17.6% CAGR during the forecast period for 2025-2034.
The healthcare sector is undergoing a significant transformation as a result of the integration of artificial intelligence (AI) with minimally invasive tools. These instruments, which are designed to reduce physical intrusion during surgical or diagnostic procedures, offer benefits such as reduced recovery time and trauma. With AI, these devices have been transformed immensely by fostering enhanced accuracy, procedural effectiveness, and safety. Algorithms of AI are used to help with real-time imaging, navigation of the device, and decision-making intraoperatively, and these include examples such as robotic-assisted surgery systems, steerable catheters, and image-based AI imaging technologies. Market growth is highly robust and stimulated by the growing need for minimally invasive treatment procedures and relentless developments in technology.
Rapid tech advancement, a growing desire to use minimally invasive procedures, and the escalating incidence of cancer and cardiovascular conditions are some key drivers. Furthermore, higher R&D spending on AI-based medical technology is fueling innovation. Still, the industry also has significant restraints. Regulatory challenges may delay device clearances, and the expensive price of sophisticated systems such as surgery robots could curb access. Also, integration difficulties, technical talent shortages, and ethical issues relating to algorithmic bias pose consistent challenges. Yet, the industry has immense scope to transform current medical practices and patient care.
Competitive Landscape:
Some of the Key Players in AI-Enhanced Minimally Invasive Devices Market:
• Medtronic Plc
• Intuitive Surgical, Inc.
• Boston Scientific Corporation
• GE HealthCare
• Fujifilm Holdings Corporation
• Stryker Corporation
• Siemens Healthineers
• Johnson & Johnson (Ethicon + Auris Health)
• Olympus Corporation
• Zimmer Biomet
• Asensus Surgical, Inc.
• CMR Surgical
• Auris Health (J&J Subsidiary)
Market Segmentation:
The AI-enhanced minimally invasive devices market is segmented by product type, application, end-user, and technology. By product type, the market is segmented into ai-enhanced catheters, ai-powered endoscopy systems, robotic-assisted surgical systems, imaging and visualization devices, and other devices. By application market is segmented into cardiology, gastroenterology, interventional radiology, orthopedics, urology and gynecology, others. By end user the market is segmented into hospitals, ambulatory surgical centers (ASCS), specialty clinics. By technology market is segmented into machine learning, computer vision, natural language processing (NLP), robotics.
Robotic-Assisted Surgical Systems Segment is Expected to Drive the AI-Enhanced Minimally Invasive Devices Market
Robotic-Assisted Surgical Systems are the most rapidly growing segment in the AI-powered minimally invasive devices market, due to their capacity to provide high precision, dexterity, and procedural efficiency in surgery. These systems utilize AI for real-time imaging and navigation, which is especially useful in complicated procedures like oncology and urology. Although AI-based endoscopy systems also hold promise through improved imaging and diagnostics, detailed growth data is scarce. Likewise, AI-powered catheters and imaging equipment have significant roles to play but are not yet being emphasized as key growth drivers. Of all the segments, robotic-assisted systems are notable for their sophisticated capabilities and increasing use across a variety of surgical specialties.
Urology and Gynecology segment is Growing at the Highest Rate in the AI-Enhanced Minimally Invasive Devices Market.
Urology and gynecology are experiencing high growth in the AI-powered minimally invasive devices market, fueled by technological advancements in robotic-assisted surgeries and AI-driven diagnostic imaging. In urology, the use of minimally invasive procedures for prostate cancer and BPH is increasing, with AI enhancing surgical accuracy, minimizing complications, and allowing personalized treatment planning through predictive analytics. In the same way, gynaecology is seeing the greater application of AI-enabled robotic systems in procedures such as hysterectomies, improving safety and accuracy. AI also enhances imaging and spatial perception, enabling surgeons to better identify critical structures and reduce risks while enabling personalized care through patient-specific data, ultimately enhancing clinical outcomes and patient satisfaction.
Regionally, North America Led the AI-Enhanced Minimally Invasive Devices Market.
North America, especially the United States, dominates the market for minimally invasive devices augmented by artificial intelligence because of its advanced healthcare system, great acceptance of new technology, and strong legal environment. Extensive adoption of these technologies is driven by the region's top-notch medical facilities and strong culture of implementing ideas including robotic-assisted surgical systems and artificial intelligence-based imaging gadgets. Furthermore, North America's developed legal framework makes it simple to approve and use products enhanced by artificial intelligence. With a 4.1% increase, heavy healthcare expenditures—totaling $4.5 trillion in the United States in 2022—further support large investments in advanced medical technologies, therefore confirming the market leadership of the area.
AI-Enhanced Minimally Invasive Devices Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 5.7 Billion |
|
Revenue Forecast In 2034 |
USD 27.8 Billion |
|
Growth Rate CAGR |
CAGR of 17.6% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Application, End-User, Technology and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Medtronic Plc, Intuitive Surgical, Inc., Boston Scientific Corporation, GE HealthCare, Fujifilm Holdings Corporation, Stryker Corporation, Siemens Healthineers, Johnson & Johnson (Ethicon + Auris Health), Olympus Corporation, Zimmer Biomet, Asensus Surgical, Inc., CMR Surgical, Auris Health (J&J Subsidiary) |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
